Rethink Group rethinks its AIM presence

Rethink Group is looking to de-list from the London Alternative Investment Market, the company announced today.
Mon, 10 Nov 2014Rethink Group is looking to de-list from the London Alternative Investment Market, the company announced today.

The group operates in the business and technology, retail, pharmaceutical and life sciences sectors. Reasons the company board is seeking the de-listing include their view that “the management time and the legal and regulatory burden” associated with being listed is “disproportionate to the benefits”.  

The announcement today also included:

  • a tender offer for up to 34,950,000 ordinary shares representing about 30% of the company’s current issued share capital at 5p per ordinary share. The offer closes at 1pm on 4 December.
  • The proposed re-registration of the company as a private limited company.

Under AIM rules, the de-listing must be approved by at least 75% of the votes cast by shareholders. If approved, the de-listing is expected to become effective on 9 December and the re-registration would then take effect on 29 December.

This morning’s announcement says that shareholders representing about 72.7% of the ordinary shares in issue today have “irrevocably agreed” to vote in favour of resolutions, including to de-list, at the company General Meeting on 26 November.

The rise and rise of agentic AI adoption

Agentic AI adoption is expected to grow 327% by 2027 as HR leaders plan to redeploy a quarter of their workforce, according to new research by Salesforce.

6 May 2025

Humly acquires London-based education recruiter

Digital education recruitment platform Humly has finalised the purchase of London-based supply agency Future Education.

Contracts 1 May 2025

HMRC to ‘revise’ IR35 CEST tool

The government has announced that its Check Employment Status for Tax (CEST) tool will be “revised” from today [30 April 2025].

Legislation 30 April 2025

Eurobase People appoints new sales director to push growth

IT/tech recruiter Eurobase People has appointed Steven Oakley (pictured) as sales director.

People 30 April 2025
Top